Tags

Type your tag names separated by a space and hit enter

[Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].
Zhongguo Yi Miao He Mian Yi. 2010 Jun; 16(3):238-40.ZY

Abstract

OBJECTIVE

To implement HepA vaccination and analyze epidemiological and serum effect.

METHODS

The children from 1 to 14 years old were vaccinated HepA since 1992 and the HepA has been integrated into EPI to the children aged 1 year in 1996. The enzyme linked immunnosortbent assay (ELISA) was used to detect Anti-Hepatitis A Virus IgG Antibody (Anti-HAV) to analyze serum effect.

RESULT

HepA coverage rate from 1 to 14 years old was 80% in 1998, and it was > 90% after the year of 2001. The coverage of 1 year old children was 95%. The incidence rate of Hepatitis A reduced continuously. The incidence of whole population reduced from 25.96/100.000 in 1992 to 6.38/100.000 in 1994. In 2007, the incidence of Heptitis A decreased 98.10% compared with the incidence of the year of 1992. Epidemiological feature of Hepatitis A was changed. The positive rate of Anti-HAV was increased after vaccination of Hepatitis A Vaccine.

CONCLUSION

The vaccination strategy for 1 to 14 years old had obviously epidemiological and serum effect.

Authors+Show Affiliations

Li JP
Weifang Prefecture Centre for Disease Control and Prevention, Weifang 261041, Shandong, China.
Gao ZX
No affiliation info available
Zhou J
No affiliation info available

MeSH

AdolescentChildChild, PreschoolChinaFemaleHepatitis AHepatitis A AntibodiesHepatitis A VaccinesHumansInfantMaleVaccination

Pub Type(s)

English Abstract
Journal Article

Language

chi

PubMed ID

20726266

Citation

Li, Jian-ping, et al. "[Analysis On Epidemiological and Serum Effect After Vaccination of Hepatitis a Vaccine (HepA)]." Zhongguo Yi Miao He Mian Yi, vol. 16, no. 3, 2010, pp. 238-40.
Li JP, Gao ZX, Zhou J. [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)]. Zhongguo Yi Miao He Mian Yi. 2010;16(3):238-40.
Li, J. P., Gao, Z. X., & Zhou, J. (2010). [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)]. Zhongguo Yi Miao He Mian Yi, 16(3), 238-40.
Li JP, Gao ZX, Zhou J. [Analysis On Epidemiological and Serum Effect After Vaccination of Hepatitis a Vaccine (HepA)]. Zhongguo Yi Miao He Mian Yi. 2010;16(3):238-40. PubMed PMID: 20726266.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)]. AU - Li,Jian-ping, AU - Gao,Zhi-xia, AU - Zhou,Jian, PY - 2010/8/24/entrez PY - 2010/8/24/pubmed PY - 2010/10/6/medline SP - 238 EP - 40 JF - Zhongguo yi miao he mian yi JO - Zhongguo Yi Miao He Mian Yi VL - 16 IS - 3 N2 - OBJECTIVE: To implement HepA vaccination and analyze epidemiological and serum effect. METHODS: The children from 1 to 14 years old were vaccinated HepA since 1992 and the HepA has been integrated into EPI to the children aged 1 year in 1996. The enzyme linked immunnosortbent assay (ELISA) was used to detect Anti-Hepatitis A Virus IgG Antibody (Anti-HAV) to analyze serum effect. RESULT: HepA coverage rate from 1 to 14 years old was 80% in 1998, and it was > 90% after the year of 2001. The coverage of 1 year old children was 95%. The incidence rate of Hepatitis A reduced continuously. The incidence of whole population reduced from 25.96/100.000 in 1992 to 6.38/100.000 in 1994. In 2007, the incidence of Heptitis A decreased 98.10% compared with the incidence of the year of 1992. Epidemiological feature of Hepatitis A was changed. The positive rate of Anti-HAV was increased after vaccination of Hepatitis A Vaccine. CONCLUSION: The vaccination strategy for 1 to 14 years old had obviously epidemiological and serum effect. SN - 1006-916X UR - https://www.unboundmedicine.com/medline/citation/20726266/[Analysis_on_epidemiological_and_serum_effect_after_vaccination_of_hepatitis_A_vaccine__HepA_]_ L2 - http://www.diseaseinfosearch.org/result/3332 DB - PRIME DP - Unbound Medicine ER -